Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue properties

Blood

Volumn 117, Issue 3, 2011, Pages 1053-1060

  Vanleene, Maximilien ^a   Saldanha, Zahraa ^a   Cloyd, Kristy L ^a   Jell, Gavin ^a   Bou Gharios, George ^a   Bassett, J H Duncan ^b   Williams, Graham R ^b   Fisk, Nicholas M ^c   Oyen, Michelle L ^d   Stevens, Molly M ^a   Guillot, Pascale V ^a   Shefelbine, Sandra J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE SIALOPROTEIN; HYDROXYPROLINE; NOGGIN; OSTEOCALCIN; OSTEOPONTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MATRIX; BONE STRENGTH; BONE TISSUE; CASE REPORT; CELL DIFFERENTIATION; CELL THERAPY; CONTROLLED STUDY; CORTICAL BONE; CRYSTAL STRUCTURE; EMBRYO; FEMALE; FEMUR FRACTURE; FETUS BLOOD; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOGENESIS IMPERFECTA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAMAN SPECTROMETRY; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; STROMA CELL; TRABECULAR BONE; WESTERN BLOTTING;

EID: 78751697407     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-05-287565     Document Type: Article

References (51)

1. Glorieux FH. Osteogenesis imperfecta. Best Pract Res Clin Rheumatol. 2008;22(1):85-100.
2. Millington-Ward S, McMahon HP, Farrar GJ. Emerging therapeutic approaches for osteogenesis imperfecta. Trends Mol Med. 2005;11(6):299-305. (Pubitemid 40804794)
3. Rauch F, Glorieux FH. Osteogenesis imperfecta. Lancet. 2004;363(9418):1377-1385.
4. Rauch F, Glorieux FH. Osteogenesis imperfecta, current and future medical treatment. Am J Med Genet C. 2005;139C:31-37. (Pubitemid 41739245)
5. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WWK. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med. 1999;5:309-313.
6. Horwitz EM, Prockop DJ, Gordon PL, et al. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood. 2001;97(5):1227.
7. Horwitz EM, Gordon PL, Koo WKK, et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci U S A. 2002;99(13):8932-8937.
8. Le Blanc K, Götherström C, Ringdén O, et al. Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation. 2005;79(11):1607-1614. (Pubitemid 40847594)
9. Guillot PV, Abass O, Bassett JH, et al. Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice. Blood. 2008;111(3):1717-1725. (Pubitemid 351213464)
10. Panaroni C, Gioia R, Lupi A, et al. In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knockin murine model for classical, dominant osteogenesis imperfecta. Blood. 2009;114(2):459-468.
11. Guillot PV, Gotherstrom C, Chan J, Kurata H, Fisk NM. Human first trimester fetal mesenchymal stem cells (MSC) express pluripotency markers, grow faster and have longer telomeres compared to adult MSC. Stem Cells. 2007;25(3):646-654. (Pubitemid 46354223)
12. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood. 2001;98:2396-2402.
13. Morrison J, Palmer DB, Cobbold S, Partridge T, Bou-Gharios G. Effects of T-lymphocyte depletion on muscle fibrosis in the mdx mouse Am J Pathol. 2005;166:1701-1710. (Pubitemid 40734393)
14. Penel G, Leroy G, Rey C, Bres E. Micro Raman spectral study of the PO4 and CO3 vibrational modes in synthetic and biological apatites. Calcif Tissue Int. 1998;63(6):475-481. (Pubitemid 28531796)
15. Tarnowski CP, Ignelzi MA, Morris MD. Mineralization of developing mouse calvaria as revealed by Raman microspectroscopy. J Bone Miner Res. 2002;17(6):1118-1126. (Pubitemid 34535151)
16. Swain RJ, Jell G, Stevens MM. Non-invasive analysis of cell cycle dynamics in single living cells with Raman micro-spectroscopy. J Cell Biochem Suppl. 2008;104:1427-1438. (Pubitemid 351961712)
17. Gentleman E, Swain RJ, Evans ND, et al. Comparative materials differences revealed in engineered bone as a function of cell-specific differentiation. Nat Mater. 2009;8:763-770.
18. Akkus O, Adar F, Schaffler MB. Age-related changes in physicochemical properties of mineral crystals are related to impaired mechanical function of cortical bone. Bone. 2004;34:443-453. (Pubitemid 38314909)
19. Oyen ML, Ko C-C. Examination of local variations in viscous, elastic, and plastic indentation responses in healing bone. J Mater Sci Mater Med. 2007;18(4):623-628.
20. Oyen ML, Cook RF. Load-displacement behaviour during sharp indentation of viscous-elastic-plastic materials. J Mater Res. 2003;18(1):139-150.
21. Oyen ML. Nanoindentation hardness of mineralized tissues. J Biomech. 2006;39(14):2699.
22. Rho JY, Zioupos P, Currey JD, Pharr GM. Variation in the individual thick lamellar properties within osteons by nanoindentation. Bone. 1999;25:295-300. (Pubitemid 29406055)
23. McCarthy EA, Raggio CL, Hossack MD, et al. Alendronate treatment for infants with osteogenesis imperfecta: demonstration of efficacy in a mouse model. Pediatr Res. 2002;52(5):660-670.
24. Misof BM, Roschger P, Baldini T, et al. Differential effects of alendronate treatment on bone from growing osteogenesis imperfecta and wild-type mouse. Bone. 2005;36(1):150-158. (Pubitemid 40128283)
25. Miles CA, Sims TJ, Camacho NP, Bailey AJ. The role of the [alpha]2 chain in the stabilization of the collagen type I heterotrimer: a study of the type I homotrimer in oim mouse tissues. J Mol Biol. 2002;321(5):797-805.
26. Aslam M, Baveja R, Liang OD, et al. Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. Am J Respir Crit Care Med. 2009;180(11):1122-1130.
27. Baer PC, Geiger H. Mesenchymal stem cell interactions with growth factors on kidney repair. Curr Opin Nephrol Hypertens. 2010;19(1):1-6.
28. Laurila JP, Laatikainen L, Castellone MD, et al. Human embryonic stem cell-derived mesenchymal stromal cell transplantation in a rat hind limb injury model Cytotherapy. 2009;11(6):726-737.
29. Xu R-X, Chen X, Chen J-H, Han Y, Han B-M. Mesenchymal stem cells promote cardiomyocyte hypertrophy in vitro through hypoxia-induced aracrine mechanisms. Clin Exp Pharmacol Physiol. 2009;36(2):176-180.
30. Schriefer JL, Robling AG, Warden SJ, Fournier AJ, Mason JJ, Turner CH. A comparison of mechanical properties derived from multiple skeletal sites in mice. J Biomech. 2005;38(3):467-475.
31. van Lenthe GH, Voide R, Boyd SK, Müller R. Tissue modulus calculated from beam theory is biased by bone size and geometry: implications for the use of three-point bending tests to determine bone tissue modulus. Bone. 2008;43(4):717-723.
32. Guo XE, Goldstein SA. Vertebral trabecular bone microscopic tissue elastic modulus and hardness do not change in ovariectomized rats. J Orthop Res. 2000;18:333-336.
33. Hengsberger S, Boivin G, Zysset PK. Morphological and mechanical properties of bone structural units: a two-case study. JSME Int J. 2002;454(4):936-943. (Pubitemid 36360533)
34. Crisostomo PR, Markel TA, Wang M, Lahm T, Lillemoe KD, Meldrum DR. In the adult mesenchymal stem cell population, source gender is a biologically relevant aspect of protective power. Surgery. 2007;142(2):215-221. (Pubitemid 47198676)
35. Deasy BM, Lu A, Tebbets JC, et al. A role for cell sex in stem cell-mediated skeletal muscle regeneration: female cells have higher muscle regeneration efficiency. J Cell Biol. 2007;177(1):73-86. (Pubitemid 46588403)
36. Ray R, Novotny NM, Crisostomo PR, Lahm T, Abarbanell A, Meldrum DR. Sex steroids and stem cell function. Mol Med. 2008;14(7):493-501.
37. Herrmann JL, Abarbanell AM, Weil BB, et al. Gender dimorphism in progenitor and stem cell function in cardiovascular disease. J Cardiovasc Transl Res. 2010;3:103-113.
38. Hong L, Sultana H, Paulius K, Zhang G. Steroid regulation of proliferation and osteogenic differentiation of bone marrow stromal cells: a gender difference. J Steroid Biochem Mol Biol. 2009;114:180-185.
39. Hong L, Zhang G, Sultana H, Yu Y, Wei Z. The effects of 17-β estradiol on enhancing proliferation of human bone marrow mesenchymal stromal cells in vitro. Stem Cells Dev. 2010 Oct 17 [Epub ahead of print[rsqsb].
40. Corsi KA, Pollett JB, Phillippi JA, Usas A, Li G, Huard J. Osteogenic potential of postnatal skeletal muscle-derived stem cells is influenced by donor sex. J Bone Miner Res. 2007;22(10):1592-1602. (Pubitemid 351229329)
41. Strube P, Mehta SS, Baerenwaldt A, et al. Sex-specific compromised bone healing in female rats might be associated with a decrease of stem cell quantity. Bone. 2009;45:1065-1072.
42. Camacho NP, Landis WJ, Boskey AL. Mineral changes in a mouse model of osteogenesis imperfecta detected by Fourier transform infrared microscopy. Connect Tissue Res. 1996;35(1):259-265. (Pubitemid 27118857)
43. Camacho NP, Hou L, Toledano TR, et al. The material basis for reduced mechanical properties in oim mice bones. J Bone Miner Res. 1999;14(2):264-272. (Pubitemid 29066252)
44. Fratzl P, Paris O, Klaushofer K, Landis WJ. Bone mineralization in an osteogenesis imperfecta mouse model studied by small-angle x-ray scattering. J Clin Invest. 1996;97(2):396-402. (Pubitemid 26039403)
45. Grabner B, Landis WJ, Roschger P, et al. Age- and genotype-dependence of bone material properties in the osteogenesis imperfecta murine model (oim). Bone. 2001;29(5):453-457. (Pubitemid 33026466)
46. Hoc T, Henry L, Verdier M, Aubry D, Sedel L, Meunier A. Effect of the microstructure on the mechanical properties of haversian cortical bone. Bone. 2006;38:466-474.
47. Huja SS, Beck FM, Thurman DT. Indentation properties of young and old osteons. Calcif Tissue Int. 2006;78(6):392-397.
48. Hengsberger S, Kulik A, Zysset P. Nanoindentation discriminates the elastic properties of individual human bone lamellae under dry and physiological condition. Bone. 2002;30(1):178-184. (Pubitemid 34048321)
49. Vetter U, Eanes ED, Kopp JB, Termine JD, Gehron Robey P. Changes in apatite crystal size in bones of patients with osteogenesis imperfecta. Calcif Tissue Int. 1991;49:248-250.
50. Jepsen KJ, Goldstein SA, Kuhn JL, Schaffler MB, Bonadio J. Type 1 collagen mutation compromises the post-yield behavior of Mov13 long bone. J Orthop Res. 1996;14(3):493-499. (Pubitemid 26199839)
51. Jepsen KJ, Schaffler MB, Kuhn JL, Goulet RW, Bonadio J, Goldstein SA. Type 1 collagen mutation alters the strength and fatigue behavior of Mov13 cortical tissue. J Biomech. 1997;30(11):1141-1147. (Pubitemid 28026503)